RD

Rajesh Deo Lal

Director Director DIN 01226929
DIN 01226929 First appointment Apr 2007 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2007
Shareholding value Locked Premium profile

About Rajesh Deo Lal

Rajesh Deo Lal has 19 years in corporate governance. Formerly with 1 company, such as Icon Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01226929
Primary Designation Director
First Appointment 25 Apr 2007
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Icon Drugs Private Limited U24231MH2002PTC134479
Additional Director 25 Apr 2007 2002 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Icon Drugs Private Limited
Premium access

Shareholding and investment profile for Rajesh Deo Lal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Deo Lal

Rajesh Deo Lal has 19 years in corporate governance. Formerly with 1 company, such as Icon Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Rajesh Deo Lal is associated with 0 companies as a director.

Rajesh Deo Lal has expertise in General Business.

Rajesh Deo Lal has 19 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available